BDNF and Alzheimer disease: In vivo evidence suggests that Aβ aggregation dramatically influence BDNF cerebrospinal fluid (CSF) level in transgenic AD mouse models (Peng et al., 2009), underlining the importance of this neurotrophic factor in AD pathogenesis, as already suggested by genetic studies (Ventriglia et al., 2002; Chen et al., 2014).